Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

PURPOSE: This phase III randomized trial (ClinicalTrials.gov identifier: NCT00337103) compared eribulin with capecitabine in patients with locally advanced or metastatic breast cancer (MBC). PATIENTS AND METHODS: Women with MBC who had received prior anthracycline- and taxane-based therapy were rand...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Oncol
Auteurs principaux: Kaufman, Peter A., Awada, Ahmad, Twelves, Chris, Yelle, Louise, Perez, Edith A., Velikova, Galina, Olivo, Martin S., He, Yi, Dutcus, Corina E., Cortes, Javier
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2015
Sujets:
ORIGINAL REPORTS
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4463422/
https://ncbi.nlm.nih.gov/pubmed/25605862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.52.4892
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires